• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

Does Coffee Consumption Reduce Dementia Risk? 

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE: 

  • Consumption of coffee or caffeine may help prevent dementia, possibly by reducing amyloid-β (Aβ) in the brain 
    • Data is currently limited  
  • Matsushita et al. (Journal of the American Geriatrics Society, 2021) examined association between caffeine consumption and dementia risk  

METHODS: 

  • Cohort study 
    • Murakami cohort study targeted all residents between 40 and 74 years, living in Murakami city, Sekikawa village, and Awashimaura village of Niigata Prefecture in Japan 
  • Participants 
    • Adults aged 40 to 74 years  
    • Japanese Cohort   
  • Exposures 
    • Consumption levels of coffee or green tea 
  • Study design 
    • Caffeine consumption was estimated from self-reported amount of coffee or green tea consumption  
    • Incidence of primary outcome was determined from a long-term care insurance database 
    • Covariate Analyses: Demographic factors | BMI | Physical activity | Energy | Smoking | Drinking | Disease history 
    • Adjusted hazard ratio (HR) calculated using Cox proportional hazards models 
  • Primary outcome 
    • Incident dementia 

RESULTS: 

  • 13,757 participants 
    • Follow-up: 8.0 years 
    • Dementia cases during the study period: 309 
  • Compared to participants who consumed <26 ml (0.9 oz) of coffee per day (1st quintile), those that consumed ≥326 ml (11 oz) per day (5th quintile) had reduced dementia risk  
    • HR 0.49 (95% CI, 0.30 to 0.79) 
    • Adjusted p for trend=0.0014 
    • In subgroup analysis 
      • Overall significant among men, not women  
      • Among ≥60 years, 5th quintile had lower HR (0.5; 95% CI, 0.29 to 0.85) for both men and women  
  • Compared to those who did not consume coffee, higher cups per day was associated with reduced dementia risk in men and women combined    
    • 2 to 2.9 cups/day: HR 0.69 (95% CI, 0.48 to 0.98) 
    • ≥3 cups/day: HR 0.53 (95% CI, 0.31 to 0.89, respectively 
  • Participants with higher caffeine consumption had a significantly lower HR than those who consumed <92 mg per day 
    • adjusted p for trend=0.0004 
  • There was no association between green tea consumption and reduced dementia risk overall but marginal significance seen in the 60 to 69 years age subgroup 

CONCLUSION: 

  • Higher levels of daily coffee and caffeine intake were dose-dependently associated with reduced dementia risk, especially among men  
  • Authors suggest possible reasons for differences between men and women  
    • Men have a higher degree of oxidative stress and benefits of caffeine may include antioxidant effect  
    • Effects of caffeine on sex hormones may differ by sex  

Learn More – Primary Sources: 

Association of coffee, green tea, and caffeine with the risk of dementia in older Japanese people 

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

The Intersection of Coffee and Genetics: Is There an Impact on Mortality?
The Missing Link between Coffee and Neuroprotection: Is it the Caffeine or Another Component?
Is Caffeine During Pregnancy Associated with Maternal Cardiometabolic Outcomes?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site